Mirjam T. Epping
Impact in
- Molecular Biology top 5%
- Histone Deacetylase Inhibitors Research
- Epigenetics and DNA Methylation
- Wnt/β-catenin signaling in development and cancer
- Retinoids in leukemia and cellular processes
- Cancer-related gene regulation
- Ubiquitin and proteasome pathways
- Protein Degradation and Inhibitors
- Immunology top 10%
- Immunotherapy and Immune Responses
Papers in
-
- Retinoids in leukemia and cellular processes 7
- Histone Deacetylase Inhibitors Research 5
- Ubiquitin and proteasome pathways 4
- Protein Degradation and Inhibitors 4
-
- Immunotherapy and Immune Responses 4
- interferon and immune responses 2
- Co-authors
- René Bernards (10 shared papers)Liming Wang (2 shared papers)Patrick O. Brown (1 shared paper)Roel Nusse (1 shared paper)Jennifer Willert (1 shared paper)Jonathan R. Pollack (1 shared paper)Michael J. Edel (1 shared paper)María Inmaculada Hernández (1 shared paper)
- Journals
- Cancer Cell (2 papers)Cell (1 paper)Cancer Discovery (1 paper)BMC Developmental Biology (1 paper)Blood (1 paper)
- Partner nations
- NetherlandsUnited StatesUnited Kingdom
In The Last Decade
Mirjam T. Epping
16 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 88
- Molecular Biology 1.2k
- Immunology 332
- Oncology 396
- Cancer Research 138
- Hematology 102
Countries citing papers authored by Mirjam T. Epping
This map shows the geographic impact of Mirjam T. Epping's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mirjam T. Epping with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mirjam T. Epping more than expected).
Fields of papers citing papers by Mirjam T. Epping
This network shows the impact of papers produced by Mirjam T. Epping. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mirjam T. Epping. The network helps show where Mirjam T. Epping may publish in the future.
Co-authors
The 25 scholars most cited alongside Mirjam T. Epping, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 352 | |
| 2 | 2002 | 335 | |
| 3 | Apoptosis: target of cancer therapy. | 2002 | 218 |
| 4 | 2009 | 113 | |
| 5 | 2010 | 105 | |
| 6 | 2009 | 102 | |
| 7 | 2008 | 92 | |
| 8 | 2014 | 80 | |
| 9 | 2006 | 79 | |
| 10 | 2007 | 66 | |
| 11 | 2009 | 65 | |
| 12 | 2012 | 53 | |
| 13 | 2015 | 35 | |
| 14 | 2009 | 22 | |
| 15 | 2008 | 15 | |
| 16 | 2024 | 1 | |
| 17 | 2026 | 0 |
About Mirjam T. Epping
Mirjam T. Epping is a scholar working on Molecular Biology, Immunology, Oncology, Cardiology and Cardiovascular Medicine and Cancer Research, having authored 17 papers that have together received 1.7k indexed citations. Recurring topics across this work include Retinoids in leukemia and cellular processes (7 papers), Histone Deacetylase Inhibitors Research (5 papers), Ubiquitin and proteasome pathways (4 papers), Immunotherapy and Immune Responses (4 papers), Protein Degradation and Inhibitors (4 papers), Acute Myocardial Infarction Research (2 papers), Cancer-related Molecular Pathways (2 papers) and interferon and immune responses (2 papers). The work is most often cited by research in Molecular Biology (1.2k citations), Immunology (332 citations), Oncology (396 citations), Cancer Research (138 citations) and Hematology (102 citations). Mirjam T. Epping has collaborated with scholars based in Netherlands, United States and United Kingdom. Frequent co-authors include René Bernards, Liming Wang, Patrick O. Brown, Roel Nusse, Jennifer Willert, Jonathan R. Pollack, Michael J. Edel, María Inmaculada Hernández, Giuseppe Giaccone and Carlos Gil Ferreira. Their work appears in journals such as Cancer Cell, Cell, Cancer Discovery, BMC Developmental Biology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.